ALVAC-CEA vaccine
Подписчиков: 0, рейтинг: 0
ALVAC-CEA vaccine is a cancer vaccine containing a canary pox virus (ALVAC) combined with the carcinoembryonic antigen (CEA) human gene.
A phase I trial in 118 patients showed safety in humans.
External links
- ALVAC-CEA vaccine entry in the public domain NCI Dictionary of Cancer Terms
This article incorporates public domain material from Dictionary of Cancer Terms. U.S. National Cancer Institute.
| Development | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Classes | |||||||||||
| Administration | |||||||||||
| Vaccines |
|
||||||||||
| Inventors/ researchers |
|||||||||||
| Controversy | |||||||||||
| Related | |||||||||||
| |||||||||||